-
21
Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
Published 2025-01-01“…Vaccines…”
Get full text
Article -
22
Multiple Gene Deletion Mutants of Equine Herpesvirus 1 Exhibit Strong Protective Efficacy Against Wild Virus Challenge in a Murine Model
Published 2025-01-01“…Vaccines…”
Get full text
Article -
23
The Addis Declaration on Immunization: Assessing the Effectiveness and Efficiency of Immunization Service Delivery Systems in Africa as of the End of 2023
Published 2024-12-01“…Vaccines…”
Get full text
Article -
24
Evaluating Families’ Opinions of Routine Influenza Vaccination in Children Under 5 Years of Age in Spain
Published 2025-01-01“…Vaccines…”
Get full text
Article -
25
Neethling Strain-Based Homologous Live Attenuated LSDV Vaccines Provide Protection Against Infection with a Clade 2.5 Recombinant LSDV Strain
Published 2024-12-01“…Vaccines…”
Get full text
Article -
26
Optimizing Varicella Vaccination Strategy: A Study on Age and Dose Impacts on Antibody Levels
Published 2024-12-01“…Vaccines…”
Get full text
Article -
27
Development of a Cationic Polymeric Micellar Structure with Endosomal Escape Capability Enables Enhanced Intramuscular Transfection of mRNA-LNPs
Published 2024-12-01“…Vaccines…”
Get full text
Article -
28
The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
Published 2025-01-01“…Vaccines…”
Get full text
Article -
29
The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
Published 2024-12-01“…Vaccines…”
Get full text
Article -
30
COVID-19 Vaccine Hesitancy Among Various Segments of the Population in Turkey: A Literature Review
Published 2025-01-01“…Vaccines…”
Get full text
Article -
31
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
Published 2024-12-01“…Vaccines…”
Get full text
Article -
32
T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection
Published 2025-01-01“…Vaccines…”
Get full text
Article -
33
Lipoprotein Signal Peptide as Adjuvants: Leveraging Lipobox-Driven TLR2 Activation in Modern Vaccine Design
Published 2025-01-01“…Vaccines…”
Get full text
Article -
34
-
35
Foodborne Infections and <i>Salmonella</i>: Current Primary Prevention Tools and Future Perspectives
Published 2024-12-01“…Vaccines…”
Get full text
Article -
36
The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences
Published 2025-01-01“…Vaccines…”
Get full text
Article -
37
-
38
-
39
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
Published 2025-01-01“…Vaccines…”
Get full text
Article -
40
Regulating Immune Responses Induced by PEGylated Messenger RNA–Lipid Nanoparticle Vaccine
Published 2024-12-01“…Vaccines…”
Get full text
Article